Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAFV599Ins)

Clinical Endocrinology

Volumn 64, Issue 1, 2006, Pages 105-109

  Carta, Claudio ^a   Moretti, Sonia ^b   Passeri, Lucia ^b   Barbi, Flavia ^b   Avenia, Nicola ^b   Cavaliere, Antonio ^b   Monacelli, Massimo ^b   Macchiarulo, Antonio ^b   Santeusanio, Fausto ^b   Tartaglia, Marco ^a   Puxeddu, Efisio ^b,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; ONCOPROTEIN; PROTEIN RET; RAS PROTEIN; VALINE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FOLLICULAR CARCINOMA; GENE INSERTION; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID CARCINOMA; THYROID TUMOR;

ADULT; AGED; CARCINOMA, PAPILLARY; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENE REARRANGEMENT; GENETIC MARKERS; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; RAS PROTEINS; THYROID NEOPLASMS;

EID: 33644947163     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02401.x     Document Type: Article

References (27)

1. Santoro M. Melillo R.M. Carlomagno F. Fusco A. Vecchio G. 2002 Molecular mechanisms of RET activation in human cancer Annals of the New York Academy of Science 963 116 121
2. Figge J. 2000 Molecular pathogenesis of thyroid cancer In Wartofsky L. ed Thyroid Cancer: a Comprehensive Guide to Clinical Management Human Press Totowa New Jersey 57 75
3. Kimura E.T. Nikiforova M.N. Zhu Z. Knauf J.A. Nikiforov Y.E. Fagin J.A. 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma Cancer Research 63 1454 1457
4. Cohen Y. Xing M. Mambo E. Guo Z. Wu G. Trink B. Beller U. Westra W.H. Ladenson P.W. Sidransky D. 2003 BRAF mutation in papillary thyroid carcinoma Journal of the National Cancer Institute 95 625 627
5. Soares P. Trovisco V. Rocha A.S. Lima J. Castro P. Preto A. Maximo V. Botelho T. Seruca R. Sobrinho-Simoes M. 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC Oncogene 22 4578 4780
6. Xu X. Quiros R.M. Gattuso P. Ain K.B. Prinz R.A. 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines Cancer Research 63 4561 4567
7. Fukushima T. Suzuki S. Mashiko M. Ohtake T. Endo Y. Takebayashi Y. Sekikawa K. Hagiwara K. Takenoshita S. Pilotti S. Collini P. Manzari A. Marubine E. Rilke F. 2003 BRAF mutations in papillary carcinomas of the thyroid Oncogene 22 6455 6457
8. Puxeddu E. Moretti S. Elisei R. Romei C. Pascucci R. Martinelli M. Marino C. Avenia N. Rossi E.D. Fadda G. Cavaliere A. Ribacchi R. Falorni A. Pontecorvi A. Pacini F. Pinchera A. Santeusanio F. 2004 BRAF (V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas Journal of Clinical Endocrinology and Metabolism 89 2414 2420
9. Fugazzola L. Mannavola D. Cirello V. Vannucchi G. Muzza M. Vicentini L. Beck-Peccoz P. 2004 BRAF mutations in an Italian cohort of thyroid cancers Clinical Endocrinology 61 239 243
10. Ciampi R. Knauf J.A. Kerler R. Gandhi M. Zhu Z. Nikiforova M.N. Rabes H.M. Fagin J.A. Nikiforov Y.E. 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer Journal of Clinical Investigations 115 94 101
11. Xing M. 2005 BRAF mutation in thyroid cancer Endocrine-Related Cancer 12 245 262
12. Trovisco V. Vieira de Castro I. Soares P. Maximo V. Silva P. Magalhaes J. Abrosimov A. Guiu X.M. Sobrinho-Simoes M. 2004 BRAF mutations are associated with some histological types of papillary thyroid carcinoma Journal of Pathology 202 247 251
13. Oler G. Ebina K.N. Michaluart P. Jr. Kimura E.T. Cerutti J. 2005 Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched lymph node metastasis reveals a new mutation in metastasis Clinical Endocrinology 62 509 511
14. Nikiforova M.N. Ciampi R. Salvatore G. Santoro M. Gandhi M. Knauf J.A. Thomas G.A. Jeremiah S. Bogdanova T.I. Tronko M.D. Fagin J.A. Nikiforov Y.E. 2004 Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas Cancer Letters 209 1 6
15. Lima J. Trovisco V. Soares P. Maximo V. Magalhaes J. Salvatore G. Santoro M. Bogdanova T. Tronko M. Abrosimov A. Jeremiah S. Thomas G. Williams D. Sobrinho-Simoes M. 2004 BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas Journal of Clinical Endocrinology and Metabolism 89 4267 4271
16. Kumagai A. Namba H. Saenko V.A. Ashizawa K. Ohtsuru A. Ito M. Ishikawa N. Sugino K. Ito K. Jeremiah S. Thomas G.A. Bogdanova T.I. Tronko M.D. Nagayasu T. Shibata Y. Yamashita S. 2004 Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas Journal of Clinical Endocrinology and Metabolism 89 4280 4284
17. Frattini M. Ferrario C. Bressan P. Balestra D. De Cecco L. Mondellini P. Bongarzone I. Collini P. Gariboldi M. Pilotti S. Pierotti M.A. Greco A. 2004 Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer Oncogene 23 7436 7340
18. Powell N. Jeremiah S. Morishita M. Dudley E. Bethel J. Bogdanova T. Tronko M. Thomas G. 2005 Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure Journal of Pathology 205 558 564
19. Trovisco V. Soares P. Preto A. de Castro I.V. Lima J. Castro P. Maximo V. Botelho T. Moreira S. Meireles A.M. Magalhaes J. Abrosimov A. Cameselle-Teijeiro J. Sobrinho-Simoes M. 2005 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness Virchows Archives Epub May 19
20. Manenti G. Pilotti S. Re F.C. Della Porta G. Pierotti M.A. 1994 Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinoma European Journal of Cancer 30A 987 993
21. Fusco A. Grieco M. Santoro M. Berlingieri M.T. Pilotti S. Pierotti M.A. Della Porta G. Vecchio G.A. 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases Nature 328 170 172
22. Namba H. Rubin S.A. Fagin J.A. 1990 Point mutations of ras oncogenes are an early event in thyroid tumorigenesis Molecular Endocrinology 4 1474 1479
23. Zhu Z. Gandhi M. Nikiforova M.N. Fischer A.H. Nikiforov Y.E. 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations American Journal of Clinical Pathology 120 71 77
24. Lemoine N.R. Mayall E.S. Wyllie F.S. Williams E.D. Goyns M. Stringer B. Wynford-Thomas D. 1989 High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis Oncogene 4 159 164
25. Suarez H.G. du Villard J.A. Severino M. Caillou B. Schlumberger M. Tubiana M. Parmentier C. Monier R. 1990 Presence of mutations in all three ras genes in human thyroid tumors Oncogene 5 565 570
26. Zhu Z. Gandhi M. Nikiforova M.N. Fischer A.H. Nikiforov Y.E. 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations American Journal of Clinical Pathology 120 71 77
27. Dibb N.J. Dilworth S.M. Mol C.D. 2004 Switching on kinases: oncogenic activation of BRAF and the PDGFR family Nature Reviews Cancer 4 718 727